IWM vs SYRE
iShares Russell 2000 ETF (IWM) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
iShares Russell 2000 ETF (IWM) common stock listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
IWM does not have a complete income-statement cache yet.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
IWM currently screens at market cap $0. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the IWM and SYRE stock pages for the full models.
Not investment advice.